EVALUATION OF MATERNAL SERUM PENTRAXIN 3 AS A NOVEL DIAGNOSTIC BIOMARKER IN GESTATIONAL DIABETES MELLITUS
Last updated: 26 Dec 2024
10.21608/alexpo.2022.124724.1377
gestational diabetes mellitus (GDM), oral glucose tolerance test (OGTT), Pentraxin 3 (PTX3)
Mohamed
Khamis
Yousri
Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University
yousrikh@yahoo.com
Manal
Swelem
Shafik
Department of obstetrics and gynaecology, Faculty of medicine
manalshafikswelem@gmail.com
Marwa
Khedr
Ibrahim Abdelhalim
Department of Medical Biochemistry, Faculty of Medicine, Alexandria University
marwa.khedr@alexmed.edu.eg
Bassant
Ibrahim
Saeed Basyouni
Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University
bsb18289@gmail.com
4
1
29866
2022-03-01
2022-03-01
2022-03-01
46
47
2682-2636
https://alexpos.journals.ekb.eg/article_224772.html
https://alexpos.journals.ekb.eg/service?article_code=224772
1
Preliminary preprint short reports of original research
1,426
Journal
ALEXMED ePosters
https://alexpos.journals.ekb.eg/
EVALUATION OF MATERNAL SERUM PENTRAXIN 3 AS A NOVEL DIAGNOSTIC BIOMARKER IN GESTATIONAL DIABETES MELLITUS
Details
Type
Article
Created At
23 Jan 2023